PolyPid’s lead product candidate D-PLEX100 is in a Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In …
A Site About 3D Stuff
PolyPid Announces Recruitment of First Patient in Revised SHIELD II Phase 3 Trial … – BioSpace
Back To Top